Skip to main content

Table 3 Type, frequency and severity of Treatment Emergent Signs and Symptoms (TESS) and number of patients experiencing at least one episode

From: Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal

Symptom

Intensity

Total n(%) of TESS

 

Mild

Moderate

Severe

Very severe

 

Abdominal pain

 

5 (10.2%)

  

5 (5.9%)

Asthenia

 

2 (4.1%)

9 (53%)

 

11(13%)

Diarrhoea

 

3 (6.1%)

  

3 (3.5%)

Headache

 

1 (2%)

1 (5.9%)

 

2 (2.4%)

Nausea

   

1 (33.3%)

1 (1.2%)

Pruritus

 

4 (8.2%)

3 (17.6%)

1 (33.3%)

8 (9.4%)

Vertigo

4 (25.%)

13 (26.5%)

2 (11.8%)

 

19 (22.3%)

Vomiting

12 (75%)

21 (42.9%)

2 (11.8%)

1 (33.3%)

36 (42.3%)

Total

16 (18.9%)

49 (57.6%)

17 (20%)

3 (3.5%)

85 (100%)